Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Assets Average: 2018-2021

Historic Assets Average for Cogent Biosciences (COGT) over the last 4 years, with Sep 2021 value amounting to $222.0 million.

  • Cogent Biosciences' Assets Average rose 159.71% to $222.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $222.0 million, marking a year-over-year increase of 159.71%. This contributed to the annual value of $150.2 million for FY2020, which is 121.90% up from last year.
  • As of Q3 2021, Cogent Biosciences' Assets Average stood at $222.0 million, which was down 4.77% from $233.1 million recorded in Q2 2021.
  • In the past 5 years, Cogent Biosciences' Assets Average registered a high of $244.3 million during Q1 2021, and its lowest value of $35.0 million during Q2 2020.
  • For the 3-year period, Cogent Biosciences' Assets Average averaged around $121.4 million, with its median value being $83.6 million (2019).
  • Its Assets Average has fluctuated over the past 5 years, first tumbled by 53.52% in 2020, then skyrocketed by 565.95% in 2021.
  • Over the past 4 years, Cogent Biosciences' Assets Average (Quarterly) stood at $90.4 million in 2018, then crashed by 40.62% to $53.7 million in 2019, then soared by 264.18% to $195.4 million in 2020, then surged by 159.71% to $222.0 million in 2021.
  • Its Assets Average stands at $222.0 million for Q3 2021, versus $233.1 million for Q2 2021 and $244.3 million for Q1 2021.